BIOLOGICAL-ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF REQUIRES MEMBRANE TARGETING BY C-TERMINAL BASIC DOMAINS

被引:66
|
作者
GONCALVES, J
SHI, B
YANG, XY
GABUZDA, D
机构
[1] DANA FARBER CANC INST,DIV HUMAN RETROVIROL,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115
关键词
D O I
10.1128/JVI.69.11.7196-7204.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 1 (HIV-1) encodes a Vif protein which is important for virus replication and infectivity. Vif is a cytoplasmic protein which exists in both membrane-associated and soluble forms. The membrane-associated form is an extrinsic membrane protein which is tightly associated with the cytoplasmic side of membranes. We have analyzed the mechanism of membrane targeting of Vif and its role in HIV-1 replication, Mutagenesis studies demonstrate that C-terminal basic domains are required for membrane association. Vif mutations which disrupt membrane association also inhibit HIV-1 replication, indicating that membrane localization of Vif is likely to be required for its biological activity in vivo. Membrane binding of Vif is almost completely abolished by trypsin treatment of membranes, These results demonstrate that membrane localization of Vif requires C-terminal basic domains and interaction with a membrane-associated protein(s), This interaction may serve to direct Vif to a specific cellular site, since immunofluorescence staining and plasma membrane fractionation studies show that Vif is localized predominantly to an internal cytoplasmic compartment rather than to the plasma membrane, The mechanism of membrane targeting of Vif is different in some respects from that of other extrinsic membrane proteins, such as Ras, Src, and MARCKS, which utilize a basic domain together with a lipid modification for membrane targeting. Membrane targeting of Vif is likely to play an important role in HIV-1 replication and thus may be a therapeutic target.
引用
收藏
页码:7196 / 7204
页数:9
相关论文
共 50 条
  • [31] PLASMA PHARMACOKINETICS AND BIOLOGICAL-ACTIVITY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZING HUMAN MONOCLONAL-ANTIBODY, F105, IN CYNOMOLGUS MONKEYS
    CAVACINI, LA
    POWER, J
    EMES, CL
    MACE, K
    TREACY, G
    POSNER, MR
    JOURNAL OF IMMUNOTHERAPY, 1994, 15 (04) : 251 - 256
  • [32] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY
    BORMAN, AM
    QUILLENT, C
    CHARNEAU, P
    DAUGUET, C
    CLAVEL, F
    JOURNAL OF VIROLOGY, 1995, 69 (04) : 2058 - 2067
  • [33] EVIDENCE FOR NEUROTOXIC ACTIVITY OF TAT FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SABATIER, JM
    VIVES, E
    MABROUK, K
    BENJOUAD, A
    ROCHAT, H
    DUVAL, A
    HUE, B
    BAHRAOUI, E
    JOURNAL OF VIROLOGY, 1991, 65 (02) : 961 - 967
  • [34] VIF IS CRUCIAL FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL DNA-SYNTHESIS IN INFECTED-CELLS
    VONSCHWEDLER, U
    SONG, JP
    AIKEN, C
    TRONO, D
    JOURNAL OF VIROLOGY, 1993, 67 (08) : 4945 - 4955
  • [35] THE SPECIFICITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 TRANSACTIVATOR IS DIFFERENT FROM THAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    EMERMAN, M
    GUYADER, M
    MONTAGNIER, L
    BALTIMORE, D
    MUESING, MA
    EMBO JOURNAL, 1987, 6 (12): : 3755 - 3760
  • [36] IMMUNOPRECIPITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 GLYCOPROTEINS BY SERA POSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ESPEJO, RT
    URIBE, P
    JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (09) : 2107 - 2110
  • [37] IDENTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG PROTEIN DOMAINS ESSENTIAL TO MEMBRANE-BINDING AND PARTICLE ASSEMBLY
    SPEARMAN, P
    WANG, JJ
    VANDERHEYDEN, N
    RATNER, L
    JOURNAL OF VIROLOGY, 1994, 68 (05) : 3232 - 3242
  • [38] COMPARATIVE ANALYSES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND HIV-2 VIF MUTANTS
    REDDY, TR
    KRAUS, G
    YAMADA, O
    LOONEY, DJ
    SUHASINI, M
    WONGSTAAL, F
    JOURNAL OF VIROLOGY, 1995, 69 (06) : 3549 - 3553
  • [39] STABILITY AND PROTEOLYTIC DOMAINS OF NEF PROTEIN FROM HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1
    FREUND, J
    KELLNER, R
    HOUTHAEVE, T
    KALBITZER, HR
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 221 (02): : 811 - 819
  • [40] CYTOMEGALOVIRUS ACTIVATES TRANSCRIPTION DIRECTED BY THE LONG TERMINAL REPEAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    BARRY, PA
    PRATTLOWE, E
    PETERLIN, BM
    LUCIW, PA
    JOURNAL OF VIROLOGY, 1990, 64 (06) : 2932 - 2940